CONNOR MCCORMICK

Allopathic & Osteopathic Physicians|Urology GREAT FALLS, MT NPI 1336766567

General Payments — all program years on this page

$3,136.62

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,421.34 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,331.3417
Education $90.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $488.4810
BAXTER HEALTHCARE $405.523
Calyxo, Inc. $176.792
Janssen Scientific Affairs, LLC $144.241
UROGEN PHARMA, INC. $116.311
Janssen Biotech, Inc. $90.001

By program year

Program yearAmountRecords
2020 $257.483
2021 $512.746
2022 $383.676
2023 $561.398
2024 $1,421.3418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078792907 Janssen Biotech, Inc. $90.00 08/10/2024 Education Undisputed 01/23/2026 View at CMS
1078853300 Janssen Scientific Affairs, LLC $144.24 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568438 Boston Scientific Corporation $120.28 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568440 Boston Scientific Corporation $146.86 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568578 Boston Scientific Corporation $1.35 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568580 Boston Scientific Corporation $1.99 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568582 Boston Scientific Corporation $8.97 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568584 Boston Scientific Corporation $16.92 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568586 Boston Scientific Corporation $25.00 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568588 Boston Scientific Corporation $29.55 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568590 Boston Scientific Corporation $55.96 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092568592 Boston Scientific Corporation $81.60 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099418390 Calyxo, Inc. $123.12 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099418395 Calyxo, Inc. $53.67 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120636680 Baxter Healthcare $145.39 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120636684 Baxter Healthcare $144.63 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120636688 Baxter Healthcare $115.50 06/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137926706 UROGEN PHARMA, INC. $116.31 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.